Market Overview:
The global cox-2 inhibitors market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for pain relief medications. The selective cox-2 inhibitors segment is expected to grow at a higher CAGR than the nonselective cox-2 inhibitors segment during the forecast period. By application, the hospital pharmacies segment is expected to account for a larger share of the global cox-2 inhibitors market than other segments during the forecast period. Geographically, North America is estimated to dominate the global cox-2 inhibitors market in 2018 and is projected to maintain its dominance throughout 2030.
Product Definition:
Cox-2 inhibitors are a class of drugs that block the enzyme cyclooxygenase-2 ( Cox-2 ). Cox-2 catalyzes the conversion of arachidonic acid to proinflammatory prostaglandins. Inhibition of Cox-2 reduces inflammation and pain.
Selective Cox-2 Inhibitors:
Cox-2 inhibitors are a class of drug used to treat pain caused by inflammation. They work by decreasing the production of prostaglandins in the body, which causes pain. The selective Cox-2 inhibitors market is expected to witness significant growth over the forecast period owing to its rising demand as second line treatment for chronic non-cancerous pain and increasing incidence rate of chronic non-cancerous pains due to growing geriatric population base worldwide.
Non Selective Cox-2 Inhibitors:
Non selective Cox-2 inhibitors are used in the treatment of severe pain due to osteoarthritis. These drugs inhibit platelet aggregation and reduce pain by decreasing prostaglandin E2 production. The mechanism of action is believed to be through inhibition of cyclooxygenase-2 (COX-2).
Application Insights:
The other application segment of the global cox-2 inhibitors market includes research studies and clinical trials. The hospital pharmacies dominated this segment in 2017, accounting for over 60% of the overall revenue share. This is owing to factors such as high product demand due to its ability to reduce pain and inflammation associated with various diseases, such as rheumatoid arthritis, osteoarthritis, gouty arthritis and fibromyalgia.
In addition, increasing awareness about these products among healthcare professionals is also expected to drive their use in hospital pharmacies over the forecast period. For instance, a study conducted by researchers from China Medical University found that coxibs have analgesic effects similar to those of opioid analgesics but without causing constipation or respiratory depression. Such trends are expected fuel product demand in hospital pharmacy applications across countries including Japan and China during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key pharmaceutical companies, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its growth. In addition, growing COX-2 therapy awareness among patients is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising healthcare expenditure and improving access due to expansion of insurance coverage by government and private agencies in countries such as China & India. Furthermore, economic development coupled with improvement in living standards has led people from lower socio-economic groups towards seeking medical treatment which will further boost revenue generation over the next eight years.
Growth Factors:
- Increasing incidence of chronic diseases such as cancer, arthritis, and cardiovascular diseases is expected to drive the demand for Cox-2 inhibitors over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth as this population is more susceptible to chronic diseases that require treatment with Cox-2 inhibitors.
- Rising awareness about the benefits of using Cox-2 inhibitors over traditional NSAIDs is projected to propel market growth in coming years.
- Technological advancements in drug delivery systems are likely to provide new opportunities for players operating in this market during the forecast period. 5) increasing research and development investments by key players are expected to fuel market growth over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Cox-2 Inhibitors Market Research Report
By Type
Selective Cox-2 Inhibitors, Non Selective Cox-2 Inhibitors
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Bayer, Novartis, Pfizer, Merck, Cadila Pharmaceuticals, Sabinsa Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Cox-2 Inhibitors Market Report Segments:
The global Cox-2 Inhibitors market is segmented on the basis of:
Types
Selective Cox-2 Inhibitors, Non Selective Cox-2 Inhibitors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Novartis
- Pfizer
- Merck
- Cadila Pharmaceuticals
- Sabinsa Corporation
Highlights of The Cox-2 Inhibitors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Selective Cox-2 Inhibitors
- Non Selective Cox-2 Inhibitors
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cox-2 Inhibitors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cox-2 inhibitors are medications that block the Cox-2 enzyme, which is responsible for the production of inflammation. This class of drugs is used to treat a variety of conditions, including heart disease, cancer, and arthritis.
Some of the major companies in the cox-2 inhibitors market are Bayer, Novartis, Pfizer, Merck, Cadila Pharmaceuticals, Sabinsa Corporation.
The cox-2 inhibitors market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cox-2 Inhibitors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cox-2 Inhibitors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cox-2 Inhibitors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cox-2 Inhibitors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cox-2 Inhibitors Market Size & Forecast, 2018-2028
4.5.1 Cox-2 Inhibitors Market Size and Y-o-Y Growth
4.5.2 Cox-2 Inhibitors Market Absolute $ Opportunity
Chapter 5 Global Cox-2 Inhibitors Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cox-2 Inhibitors Market Size Forecast by Type
5.2.1 Selective Cox-2 Inhibitors
5.2.2 Non Selective Cox-2 Inhibitors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cox-2 Inhibitors Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cox-2 Inhibitors Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cox-2 Inhibitors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cox-2 Inhibitors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cox-2 Inhibitors Analysis and Forecast
9.1 Introduction
9.2 North America Cox-2 Inhibitors Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cox-2 Inhibitors Market Size Forecast by Type
9.6.1 Selective Cox-2 Inhibitors
9.6.2 Non Selective Cox-2 Inhibitors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cox-2 Inhibitors Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cox-2 Inhibitors Analysis and Forecast
10.1 Introduction
10.2 Europe Cox-2 Inhibitors Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cox-2 Inhibitors Market Size Forecast by Type
10.6.1 Selective Cox-2 Inhibitors
10.6.2 Non Selective Cox-2 Inhibitors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cox-2 Inhibitors Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cox-2 Inhibitors Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cox-2 Inhibitors Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cox-2 Inhibitors Market Size Forecast by Type
11.6.1 Selective Cox-2 Inhibitors
11.6.2 Non Selective Cox-2 Inhibitors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cox-2 Inhibitors Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cox-2 Inhibitors Analysis and Forecast
12.1 Introduction
12.2 Latin America Cox-2 Inhibitors Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cox-2 Inhibitors Market Size Forecast by Type
12.6.1 Selective Cox-2 Inhibitors
12.6.2 Non Selective Cox-2 Inhibitors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cox-2 Inhibitors Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cox-2 Inhibitors Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cox-2 Inhibitors Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cox-2 Inhibitors Market Size Forecast by Type
13.6.1 Selective Cox-2 Inhibitors
13.6.2 Non Selective Cox-2 Inhibitors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cox-2 Inhibitors Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cox-2 Inhibitors Market: Competitive Dashboard
14.2 Global Cox-2 Inhibitors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Novartis
14.3.3 Pfizer
14.3.4 Merck
14.3.5 Cadila Pharmaceuticals
14.3.6 Sabinsa Corporation
